BRPI0520049A2 - composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma - Google Patents
composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesmaInfo
- Publication number
- BRPI0520049A2 BRPI0520049A2 BRPI0520049-0A BRPI0520049A BRPI0520049A2 BR PI0520049 A2 BRPI0520049 A2 BR PI0520049A2 BR PI0520049 A BRPI0520049 A BR PI0520049A BR PI0520049 A2 BRPI0520049 A2 BR PI0520049A2
- Authority
- BR
- Brazil
- Prior art keywords
- osteoblast
- fibrin
- semi
- bone
- solid
- Prior art date
Links
- 210000000963 osteoblast Anatomy 0.000 title abstract 10
- 102000009123 Fibrin Human genes 0.000 title abstract 5
- 108010073385 Fibrin Proteins 0.000 title abstract 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical group CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title abstract 5
- 229950003499 fibrin Drugs 0.000 title abstract 5
- 210000000988 bone and bone Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000008247 solid mixture Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 239000007787 solid Substances 0.000 abstract 4
- 208000010392 Bone Fractures Diseases 0.000 abstract 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 239000007758 minimum essential medium Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
COMPOSIçãO SEMI-SóLIDA DE OSTEOBLASTOS CONTENDO FIBRINA PARA A UNIãO OSSEA E MéTODO PARA O PREPARO DA MESMA. Cujo método compreende o isolamento dos osteoblastos de um tecido ósseo e o cultivo/proliferação dos osteoblastos isolados, no meio de cultura DMEM (Dulbecco's Modified Eagle's Medium) ou ci - MEM (Minimum Essential Medium, Alpha Modification), para o preparo de uma suspensão de osteoblastos, e a mistura da suspensão de osteoblastos resultantes com um fator de coagulação, para o preparo de um agente terapêutico de osteoblastos. De acordo com a presente invenção, cuja construção é feita de acordo com a descrição acima mencionada, é possível realizar o enxerto ósseo e, consequentemente, a união óssea, sem apresentar nenhuma rejeição clínica ao enxerto, com distribuição uniforme dos osteoblastos, através da injeção de uma mistura constituída de osteoblastos e fibrina, nas partes afetadas, para a união óssea, sendo que a união óssea é obtida de forma rápida e eficaz, através da injeção constante de uma composição semi-sólida de osteoblastos, nas partes afetadas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR102005-0050450 | 2005-06-13 | ||
| KR1020050050450A KR100702250B1 (ko) | 2005-06-13 | 2005-06-13 | 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법 |
| PCT/KR2005/002531 WO2006135126A1 (en) | 2005-06-13 | 2005-08-03 | Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0520049A2 true BRPI0520049A2 (pt) | 2009-04-14 |
| BRPI0520049B1 BRPI0520049B1 (pt) | 2020-12-22 |
| BRPI0520049B8 BRPI0520049B8 (pt) | 2021-05-25 |
Family
ID=37532459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0520049A BRPI0520049B8 (pt) | 2005-06-13 | 2005-08-03 | composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20080213229A1 (pt) |
| EP (1) | EP1890713B1 (pt) |
| JP (1) | JP2008532723A (pt) |
| KR (1) | KR100702250B1 (pt) |
| CN (1) | CN101247814A (pt) |
| AT (1) | ATE503486T1 (pt) |
| BR (1) | BRPI0520049B8 (pt) |
| CY (1) | CY1111795T1 (pt) |
| DE (1) | DE602005027260D1 (pt) |
| DK (1) | DK1890713T3 (pt) |
| ES (1) | ES2362430T3 (pt) |
| HR (1) | HRP20110391T1 (pt) |
| MX (1) | MX2007012041A (pt) |
| PL (1) | PL1890713T3 (pt) |
| PT (1) | PT1890713E (pt) |
| RS (1) | RS51724B (pt) |
| SG (1) | SG162750A1 (pt) |
| SI (1) | SI1890713T1 (pt) |
| WO (1) | WO2006135126A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101037002B1 (ko) * | 2008-09-30 | 2011-05-25 | 세원셀론텍(주) | 연골세포 조기배양을 위한 연골세포 특이적 배양방법 |
| KR100932945B1 (ko) | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
| KR100932948B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | Ｂｍｐ-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
| WO2020161747A1 (en) * | 2019-02-08 | 2020-08-13 | Regrow Biosciences Private Limited | Osteoblast cell-mixture, and implementations thereof |
| CN113827778B (zh) * | 2021-11-03 | 2022-10-21 | 浙江赛灵特医药科技有限公司 | 一种注射式骨修复剂及其应用 |
| CN113975468A (zh) * | 2021-11-11 | 2022-01-28 | 成都中科娥皇健康咨询有限公司 | 一种骨膜组织老化修复剂及其制备工艺 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972703A (en) * | 1994-08-12 | 1999-10-26 | The Regents Of The University Of Michigan | Bone precursor cells: compositions and methods |
| US6599515B1 (en) * | 1995-01-16 | 2003-07-29 | Baxter International Inc. | Fibrin porous structure |
| DE19949290A1 (de) * | 1999-10-12 | 2001-04-26 | Albrecht Bettermann | Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin |
| DE19956503A1 (de) * | 1999-11-24 | 2001-06-21 | Universitaetsklinikum Freiburg | Spritzbares Knochenersatzmaterial |
| EP1259196A2 (en) * | 2000-03-03 | 2002-11-27 | Smith & Nephew, Inc. | Shaped particle and composition for bone deficiency and method of making the particle |
| IL144446A0 (en) * | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
| KR100522457B1 (ko) * | 2002-04-13 | 2005-10-18 | 주식회사 셀론텍 | 뼈세포의 배양방법 및 조성물 |
| JP2006527032A (ja) * | 2003-06-12 | 2006-11-30 | インターフェース バイオテック エー／エス | 細胞の体内移植法 |
| US7316822B2 (en) * | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
-
2005
- 2005-06-13 KR KR1020050050450A patent/KR100702250B1/ko not_active Expired - Fee Related
- 2005-08-03 DE DE602005027260T patent/DE602005027260D1/de not_active Expired - Lifetime
- 2005-08-03 JP JP2008502891A patent/JP2008532723A/ja active Pending
- 2005-08-03 HR HR20110391T patent/HRP20110391T1/hr unknown
- 2005-08-03 SG SG201003922-0A patent/SG162750A1/en unknown
- 2005-08-03 US US11/885,943 patent/US20080213229A1/en not_active Abandoned
- 2005-08-03 EP EP05774219A patent/EP1890713B1/en not_active Expired - Lifetime
- 2005-08-03 PT PT05774219T patent/PT1890713E/pt unknown
- 2005-08-03 ES ES05774219T patent/ES2362430T3/es not_active Expired - Lifetime
- 2005-08-03 DK DK05774219.9T patent/DK1890713T3/da active
- 2005-08-03 MX MX2007012041A patent/MX2007012041A/es active IP Right Grant
- 2005-08-03 BR BRPI0520049A patent/BRPI0520049B8/pt not_active IP Right Cessation
- 2005-08-03 SI SI200531313T patent/SI1890713T1/sl unknown
- 2005-08-03 CN CNA2005800492946A patent/CN101247814A/zh active Pending
- 2005-08-03 AT AT05774219T patent/ATE503486T1/de active
- 2005-08-03 RS RS20110212A patent/RS51724B/sr unknown
- 2005-08-03 WO PCT/KR2005/002531 patent/WO2006135126A1/en not_active Ceased
- 2005-08-03 PL PL05774219T patent/PL1890713T3/pl unknown
-
2011
- 2011-06-28 CY CY20111100616T patent/CY1111795T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1890713A1 (en) | 2008-02-27 |
| ES2362430T3 (es) | 2011-07-05 |
| BRPI0520049B1 (pt) | 2020-12-22 |
| PL1890713T3 (pl) | 2011-09-30 |
| EP1890713B1 (en) | 2011-03-30 |
| MX2007012041A (es) | 2008-03-10 |
| CY1111795T1 (el) | 2015-10-07 |
| DK1890713T3 (da) | 2011-06-27 |
| JP2008532723A (ja) | 2008-08-21 |
| BRPI0520049B8 (pt) | 2021-05-25 |
| US20080213229A1 (en) | 2008-09-04 |
| DE602005027260D1 (de) | 2011-05-12 |
| ATE503486T1 (de) | 2011-04-15 |
| WO2006135126A1 (en) | 2006-12-21 |
| KR100702250B1 (ko) | 2007-04-03 |
| RS51724B (sr) | 2011-10-31 |
| CN101247814A (zh) | 2008-08-20 |
| SG162750A1 (en) | 2010-07-29 |
| SI1890713T1 (sl) | 2011-07-29 |
| KR20060129795A (ko) | 2006-12-18 |
| EP1890713A4 (en) | 2009-07-08 |
| PT1890713E (pt) | 2011-06-09 |
| HRP20110391T1 (hr) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fennema et al. | Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study | |
| Nourissat et al. | Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model | |
| Evenbratt et al. | Insights into the present and future of cartilage regeneration and joint repair | |
| Wilson et al. | Adipose-derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of swine | |
| Chai et al. | Injectable photo-crosslinked bioactive BMSCs-BMP2-GelMA scaffolds for bone defect repair | |
| Orsi et al. | A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats | |
| Sadeghinia et al. | Nano-hydroxy apatite/chitosan/gelatin scaffolds enriched by a combination of platelet-rich plasma and fibrin glue enhance proliferation and differentiation of seeded human dental pulp stem cells | |
| CY1111795T1 (el) | Συνθεση οστεοβλαστη ημιστερεοποιημενης αναμεμιγμενης φιμπρινης για συγκολληση καταγματος οστου και η μεθοδος παρασκευης αυτης | |
| Neubauer et al. | The Effect of Blood‐Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose‐Derived Mesenchymal Stem Cells Originated from Three Different Locations | |
| Wang et al. | Hydrogel fibers encapsulating human stem cells in an injectable calcium phosphate scaffold for bone tissue engineering | |
| Wei et al. | Effect of mesenchymal stem cells and platelet‐rich plasma on the bone healing of ovariectomized rats | |
| El‐Jawhari et al. | Collagen‐containing scaffolds enhance attachment and proliferation of non‐cultured bone marrow multipotential stromal cells | |
| Tschon et al. | Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis | |
| Montes-Medina et al. | Effect of bone marrow stromal cells in combination with biomaterials in early phases of distraction osteogenesis: An experimental study in a rabbit femur model | |
| Zou et al. | Phenotypic, trophic, and regenerative properties of mesenchymal stem cells from different osseous tissues | |
| Xie et al. | Effects of PRP and LyPRP on osteogenic differentiation of MSCs | |
| Pagani et al. | Update on synthetic biomaterials combined with fibrin derivatives for regenerative medicine: Applications in bone defect treatment: Systematic review | |
| Chen et al. | Synergetic effects of hBMSCs and hPCs in osteogenic differentiation and their capacity in the repair of critical-sized femoral condyle defects | |
| CY1111582T1 (el) | Συνθεση σχηματισμου οστου που αποτελειται απο μιγμα οστεοβλαστη και βιο-θεμελιας ουσιας και μεθοδος παρασκευης αυτης | |
| Zhong et al. | In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma | |
| Von Wilmowsky et al. | Reconstruction of a mandibular defect with autogenous, autoclaved bone grafts and tissue engineering: an in vivo pilot study | |
| MY136958A (en) | Semi-solid osteoblast composition containing fibrin for bone union and method preparing the same | |
| WO2022092169A1 (ja) | 骨形成組成物およびその用途 | |
| KR20130133612A (ko) | ＰＲＰ(Ｐｌａｔｅｌｅｔ－Ｒｉｃｈ Ｐｌａｓｍａ)를 유효성분으로 포함하는 세포 부착능 및 귀소능 증진용 조성물 | |
| Di Stefano et al. | Cellular interactions and gene expression analysis of two equine-derived bone graft materials: an in vitro study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/08/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2681 DE 24-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |